HeartSciences Inc. 8-K Summary
Business Context and Reporting Period
HeartSciences Inc. (HSCS) filed this Current Report on Form 8-K on November 7, 2024, to disclose the results of its Annual Meeting of Stockholders held on the same date. The Company is incorporated in Texas and its securities trade on The Nasdaq Stock Market LLC.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report is limited to the disclosure of stockholder voting results.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely addresses the outcome of two proposals submitted to security holders.
Management Commentary and Voting Results
Shareholders voted on two proposals at the Annual Meeting:
- Proposal 1: Auditor Ratification - Shareholders ratified the appointment of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending April 30, 2025.
- For: 413,499
- Against: 9,896
- Abstain: 1,116
- Proposal 2: Adjournment - Shareholders approved the ability to adjourn the meeting to solicit additional proxies if necessary.
- For: 367,736
- Against: 18,963
- Abstain: 37,811
No other matters were considered or voted upon.
Key Facts for Investor Verification
- Confirmation that Haskell & White LLP is the appointed auditor for the fiscal year ending April 30, 2025.
- Verification of the total number of shares voted and the approval margins for both proposals.
- Review of the Company's upcoming 10-K or 10-Q filings for the actual financial performance data not included in this 8-K.